Daiichi-Sankyo (Japan)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi-Sankyo (Japan), Japan, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
45%
Total
Publications
5.5K
Total Open
Publications
2.5K
Total
Citations
181K
Open Access
Percentage
45%
Total
Publications
5.5K
Total Open
Publications
2.5K
Total
Citations
181K
Breakdown
Publisher Open
23%
Both
18%
Other Platform Open
4%
Closed
55%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 31%
706
Hybrid 25%
563
No Guarantees 44%
980
Other Platform Open
Domain 81%
973
Other Internet 16%
190
Institution 16%
189
Public 3%
39
Preprint 2%
20
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 975 |
DOI | Other Internet | 184 |
DANS - Data Archiving and Networked Services | Institution | 61 |
Europe PMC | Domain | 54 |
Figshare | Public | 37 |
Research Square | Preprint | 17 |
universiteitleiden.nl OAI-PMH Repository | Institution | 13 |
Digital Access to Libraries | Institution | 11 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 10 |
King's College London - Research Portal | Institution | 10 |